| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3YN0602W4W |
| InChI Key | PKXWXXPNHIWQHW-RCBQFDQVSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H27N3O4 |
| Molecular Weight | 361.44 |
| AlogP | 0.38 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 98.74 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Gamma-secretase inhibitor | PubMed |
| Primary Target | |
|---|---|
| presenilin 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Aspartic protease
Aspartic protease AD clan
Aspartic protease A22A subfamily
Aspartic protease A22A regulatory subfamily
|
126 | 3-200 | - | - | - | |
|
Enzyme
|
126 | 3-200 | - | - | - | |
|
Ion channel
Other ion channel
Miscellaneous ion channel
Presenilin ER Ca2+ leak channel family
|
126 | 3-200 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 425386-60-3 |
| ChEBI | 131158 |
| ChEMBL | CHEMBL520733 |
| DrugBank | DB12463 |
| EPA CompTox | DTXSID10235740 |
| FDA SRS | 3YN0602W4W |
| Guide to Pharmacology | 6978 |
| PDB | ESF |
| PubChem | 9843750 |
| SureChEMBL | SCHEMBL417581 |
| ZINC | ZINC000003989041 |